1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
61F85C774BFF88F5765257D0A003A1B7F
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-preparing-medical-science-liaison-teams-for-a-changing-environment-team-size-and-deployment?opendocument
18
19opendocument
2018.212.83.37
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Medical Affairs Medical Science Liaison

Preparing Medical Science Liaison Teams for a Changing Environment: Team Size and Deployment

ID: 5314


Features:

9 Info Graphics

10 Data Graphics

141 Metrics


Pages/Slides: 26


Published: 2014


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from "Preparing Medical Science Liaison Teams for a Changing Environment: Team Size and Deployment"


STUDY OVERVIEW

Medical Science Liaison (MSL) teams face a rapidly changing healthcare environment that requires organizations to have their MSL teams appropriately sized and deployed. Best Practices, LLC conducted this research to identify the drivers of MSL team size and explore factors affecting deployment. Insights and metrics in the study will help companies field a more efficient and effective medical field team.

KEY TOPICS

  • Medical Liaisons: Size Of Medical Science Liaison Teams
  • Medical Liaisons: Effective Operations Of Medical Science Liaison Teams

SAMPLE KEY METRICS
  • Regional demographics of participants
  • Title of respondents
  • Geographic span of responsibility of medical affairs at participating companies
  • Product scope of MSLs
  • Factors to determine team size
  • Internal stakeholder needs
  • Deployment of medical liaisons into the field in mature and emerging markets
  • Factors causing increase in the number of medical science liaisons
  • Factors causing decrease in the number of medical science liaisons

SAMPLE KEY FINDING

Determining Medical Science Liaison Teams’ Size: Mature Markets and Emerging Markets companies employ different strategies when determining the size of Medical Science Liaisons. Mature markets companies use company or product related factors such as “Corporate Commitment to a Franchise” or “Product Life Cycle” more often than Emerging Markets companies. Emerging Markets companies typically use an external factor, “Number of Thought Leaders,” to determine Medical Science Liaison teams’ size.

METHODOLOGY

This study engaged executives from 32 leading healthcare companies. Segmentation analysis was key to examining trends and effective practices. Twenty three participants make up the Mature Markets Segment, while the Emerging Markets Segment consists of seven participants from Brazil, India and other Asia markets. This report includes Mature and Emerging Markets segments’ analysis.

Industries Profiled:
Biotech; Health Care; Pharmaceutical; Biopharmaceutical; Clinical Research; Laboratories; Chemical; Medical Device


Companies Profiled:
Acorda Therapeutics; United Therapeutics; Sanofi; Upsher-Smith; Kadmon Pharmaceuticals; Shire; Crescendo Bioscience; Teva Pharmaceutical Industries Ltd; Lilly; Baxter BioScience; Merck; Cubist Pharmaceuticals; Pierre Fabre Medicament; Amgen; ProStrakan; Dr Reddy's Laboratories; Biocon; Genentech; Astellas; Ironwood; Biogen Idec; AstraZeneca; Covidien


If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.